P617: FIXED-DURATION (FD) IBRUTINIB + VENETOCLAX FOR FIRST-LINE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)/SMALL LYMPHOCYTIC LYMPHOMA (SLL): 4-Y FOLLOW-UP FROM FD COHORT OF PHASE 2 CAPTIVATE STUDY

Authors: Paolo Ghia, John Allan, Tanya Siddiqi, William G. Wierda, Constantine Tam, Carol Moreno, Alessandra Tedeschi, Edith Szafer-Glusman, Cathy Zhou, Chris Abbazio, Jim Dean, Anita Szoke, Paul M. Barr

Source: HemaSphere, Vol 7, p e2822842 (2023)

Subject Terms: Diseases of the blood and blood-forming organs, RC633-647.5

File Description: electronic resource

Relation: http://journals.lww.com/10.1097/01.HS9.0000969372.28228.42; https://doaj.org/toc/2572-9241

Access URL: https://doaj.org/article/8d8716a5908d4a09b0fedb6fa9d0dbce

P627: LONG-TERM OUTCOMES WITH CONTINUOUS IBRUTINIB IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA: ANALYSIS OF TIME TO PROGRESSION

Authors: Thomas Kipps, Carolyn Owen, Ian W. Flinn, Paul M. Barr, Alessandra Tedeschi, Richard Greil, Edith Szafer-Glusman, Hsin-Hui Huang, Lynne Neumayr, Chris Abbazio, Tait Shanafelt

Source: HemaSphere, Vol 7, p e4326761 (2023)

Subject Terms: Diseases of the blood and blood-forming organs, RC633-647.5

File Description: electronic resource

Relation: http://journals.lww.com/10.1097/01.HS9.0000969412.43267.61; https://doaj.org/toc/2572-9241

Access URL: https://doaj.org/article/c10f8872813c4deca3ad7def8184f141

P645: IBRUTINIB FOR TREATMENT OF RELAPSED-REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA: A MATCHING-ADJUSTED INDIRECT COMPARISON OF 3 RANDOMIZED PHASE 3 TRIALS

Authors: Paolo Ghia, Talha Munir, Jan Burger, John Seymour, Kerry Rogers, Hsin-Hui Huang, Carol Moreno, Lynne Neumayr, Chris Abbazio, Jeff Sharman

Source: HemaSphere, Vol 7, p e78258de (2023)

Subject Terms: Diseases of the blood and blood-forming organs, RC633-647.5

File Description: electronic resource

Relation: http://journals.lww.com/10.1097/01.HS9.0000969484.78258.de; https://doaj.org/toc/2572-9241

Access URL: https://doaj.org/article/b8d69d0ef3924d15848b98949326ec5b